EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of cystatin C proteoforms with estimated glomerular filtration rate

Olgica Trenchevska, Juraj Koska, Shripad Sinari, Hussein Yassine, Peter D Reaven, Dean D Billheimer, Randall W Nelson, Dobrin Nedelkov

Clinical Mass Spectrometry · 2016

DOI: 10.1016/j.clinms.2016.11.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Mass Spectrometry, 2016. Verfasst von Olgica Trenchevska und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Biodesign Institute, Arizona State University, Tempe, AZ, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cystatin C (CysC), a marker for chronic kidney disease, exists as three sequence proteoforms, in addition to the wild-type sequence: one contains hydroxyproline at position 3 (3Pro-OH), the two others have truncated sequences (des-S and des-SSP). Here, we examine correlations between each of these CysC proteoforms and estimated glomerular filtration rate (eGFR), a diagnostic criterion for chronic kidney disease (CKD).

Methods

CysC proteoform concentrations were determined from the plasma of 297 diabetes patients at a baseline time point and nine-months later, using a mass spectrometric immunoassay, and were correlated with eGFR calculations.

Results

In all samples, 3Pro-OH was the most abundant CysC proteoform, followed by the wild-type proteoform. Least abundant were the truncated CysC proteoforms, des-S and des-SSP, although they demonstrated stronger negative correlation with eGFR than the 3Pro-OH and wild-type proteoforms. The des-SSP truncated proteoform exhibited negative predictive value for eGFR.

Conclusions

The truncated CysC proteoforms show potential for clinical and prognostic utility in CKD staging. This could be useful in populations where current methods do not provide satisfactory solutions.

Schlagwörter

Stichwörter der Autor:innen

Cystatin CGFRimmunoassaymass spectrometryproteoforms

Autor:innen und Institutionen

  • The Biodesign Institute, Arizona State University, Tempe, AZ, USA.
  • Department of Medicine, Phoenix Veteran Affairs Medical Center, Phoenix, AZ, USA.
  • Biostatics Consulting Lab, University of Arizona, Tucson, AZ, USA.
  • Department of Medicine, University of Southern California, Los Angeles, USA.

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIEHS NIH HHS
  • NHLBI
  • NIEHS

Zitieren

APA

Trenchevska, O., Koska, J., Sinari, S., Yassine, H., Reaven, P. D., Billheimer, D. D., Nelson, R. W., & Nedelkov, D. (2016). Association of cystatin C proteoforms with estimated glomerular filtration rate. Clinical Mass Spectrometry. https://doi.org/10.1016/j.clinms.2016.11.001

Vancouver

Trenchevska O, Koska J, Sinari S, Yassine H, Reaven PD, Billheimer DD, et al. Association of cystatin C proteoforms with estimated glomerular filtration rate. Clinical Mass Spectrometry. 2016. doi:10.1016/j.clinms.2016.11.001

BibTeX
@article{Trenchevska2016,
  author = {Trenchevska, Olgica and Koska, Juraj and Sinari, Shripad and Yassine, Hussein and Reaven, Peter D and Billheimer, Dean D and Nelson, Randall W and Nedelkov, Dobrin},
  title = {Association of cystatin C proteoforms with estimated glomerular filtration rate},
  journal = {Clinical Mass Spectrometry},
  year = {2016},
  doi = {10.1016/j.clinms.2016.11.001}
}
Kostenlos starten →